Michael Cronquist Christensen

18PUBLICATIONS
21CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingMolecular medicineEpidemiological methodsLabour, migration and development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 27, 2026
Vortioxetine in Subgroups of Patients with Major Depressive Disorder and Early-Stage Dementia: Further Results from the MEMORY Study.

Iria Grande, Simon Nitschky Schmidt, Elin Reines

|Oct 28, 2024
Efficacy of vortioxetine versus desvenlafaxine in the treatment of functional impairment in patients with major depressive disorder: Results from the multinational VIVRE study.

Michael Cronquist Christensen, Iria Grande, Andreas Rieckmann

|Aug 05, 2024
Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study.

Michael Cronquist Christensen, Francesca Canellas, Henrik Loft

|Jul 30, 2024
Effectiveness of vortioxetine in elderly patients with major depressive disorder in real-world clinical practice: Results from the RELIEVE study.

M Di Nicola, M Adair, A Rieckmann

|Jun 12, 2024
Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study.

Gang Wang, Tianmei Si, Andreas Rieckmann

|Dec 21, 2023
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets.

Andrea Fagiolini, Michael Adair, Kamilla Buchberg Petersen

Pageof 3

Frequent Collaborators

7 joint publications

Andrea Fagiolini

6 joint publications

Hongye Ren

4 joint publications

Michael Adair

3 joint publications

Roger S McIntyre